Lapierre, Thibault Joseph William Jacques Dit 
; Cruz, Mariza Gabriela Faleiro de Moura Lodi; Barbosa, Gisele; Costa, Analu Rocha ; Chávez-Fumagalli, Miguel Angel ; Froes, Thamires Quadros ; Ramos, Priscila Zonzini; Macruz, Paula Derksen; Trindade, Thalita Carolyne Souza; Pilau, Eduardo Jorge ; Veras, Patricia Sampaio Tavares; Nonato, Maria Cristina ; Massirer, Katlin Brauer ; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini ; Lima, Lídia Moreira ; Murta, Silvane Maria Fonseca ; Rezende Junior, Celso de Oliveira
Fonte: ACS Pharmacology and Translational Science. Unidades: FCFRP, IFSC
Assuntos: LEISHMANIA, CRISTALOGRAFIA, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAPIERRE, Thibault Joseph William Jacques Dit et al. Hit-to-lead studies of pyrazinylpiperazines against visceral Leishmaniasis: pharmacokinetic profile and in vivo efficacy of potent compounds against Leishmania infantum. ACS Pharmacology and Translational Science, v. 8, n. 8, p. 2736–2755 + supporting information, 2025Tradução . . Disponível em: https://doi.org/10.1021/acsptsci.5c00318. Acesso em: 08 out. 2025.APA
Lapierre, T. J. W. J. D., Cruz, M. G. F. de M. L., Barbosa, G., Costa, A. R., Chávez-Fumagalli, M. A., Froes, T. Q., et al. (2025). Hit-to-lead studies of pyrazinylpiperazines against visceral Leishmaniasis: pharmacokinetic profile and in vivo efficacy of potent compounds against Leishmania infantum. ACS Pharmacology and Translational Science, 8( 8), 2736–2755 + supporting information. doi:10.1021/acsptsci.5c00318NLM
Lapierre TJWJD, Cruz MGF de ML, Barbosa G, Costa AR, Chávez-Fumagalli MA, Froes TQ, Ramos PZ, Macruz PD, Trindade TCS, Pilau EJ, Veras PST, Nonato MC, Massirer KB, Ferreira LLG, Andricopulo AD, Lima LM, Murta SMF, Rezende Junior C de O. Hit-to-lead studies of pyrazinylpiperazines against visceral Leishmaniasis: pharmacokinetic profile and in vivo efficacy of potent compounds against Leishmania infantum [Internet]. ACS Pharmacology and Translational Science. 2025 ; 8( 8): 2736–2755 + supporting information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsptsci.5c00318Vancouver
Lapierre TJWJD, Cruz MGF de ML, Barbosa G, Costa AR, Chávez-Fumagalli MA, Froes TQ, Ramos PZ, Macruz PD, Trindade TCS, Pilau EJ, Veras PST, Nonato MC, Massirer KB, Ferreira LLG, Andricopulo AD, Lima LM, Murta SMF, Rezende Junior C de O. Hit-to-lead studies of pyrazinylpiperazines against visceral Leishmaniasis: pharmacokinetic profile and in vivo efficacy of potent compounds against Leishmania infantum [Internet]. ACS Pharmacology and Translational Science. 2025 ; 8( 8): 2736–2755 + supporting information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsptsci.5c00318
